Activity
By date
Descending
  • Four Pillars of Life Sciences Speed to Market

    People are more aware than ever of the many amazing ways new treatments can improve their lives. As a result, life sciences companies are under more pressure than ever to safely deliver new, innovative treatments to market to satisfy customer demand. The key to accelerating that pipeline is based around four pillars of digitalization that Emerson experts Michalle Adkins and Karen Fung share in a recent Q&A in BioPharma…
  • Smart Maintenance Practices in Biopharmaceutical Manufacturing

    As the Industrial Internet of Things enables more and more wireless instrumentation, the ability to transform maintenance practices to become more predictive grows. While companies in several industries have moved to predictive maintenance practices, companies in other sectors have been somewhat slower to adopt them. In a new paper published by the BioPhorum organization, Smart Maintenance Architecture: A Data-Driven…
  • Smart Maintenance Practices in Biopharmaceutical Manufacturing

    As the Industrial Internet of Things enables more and more wireless instrumentation, the ability to transform maintenance practices to become more predictive grows. While companies in several industries have moved to predictive maintenance practices, companies in other sectors have been somewhat slower to adopt them. In a new paper published by the BioPhorum organization, Smart Maintenance Architecture: A Data-Driven…
  • What Is Emerson’s Rapid Engineered Solutions Program?

    Rapid Engineered Solutions help analytical and medical equipment manufacturers accelerate the fluid handling design and engineering phase of new product development. Are you an analytical or medical OEM design engineer struggling with compressed product development timelines? Do you need a rapid solution to complex fluidic system challenges? The Rapid Engineered Solutions program from Emerson is the perfect solution…
  • What Is Emerson’s Rapid Engineered Solutions Program?

    Rapid Engineered Solutions help analytical and medical equipment manufacturers accelerate the fluid handling design and engineering phase of new product development. Are you an analytical or medical OEM design engineer struggling with compressed product development timelines? Do you need a rapid solution to complex fluidic system challenges? The Rapid Engineered Solutions program from Emerson is the perfect solution…
  • What Is Emerson’s Rapid Engineered Solutions Program?

    Rapid Engineered Solutions help analytical and medical equipment manufacturers accelerate the fluid handling design and engineering phase of new product development. Are you an analytical or medical OEM design engineer struggling with compressed product development timelines? Do you need a rapid solution to complex fluidic system challenges? The Rapid Engineered Solutions program from Emerson is the perfect solution…
  • What Is Emerson’s Rapid Engineered Solutions Program?

    Rapid Engineered Solutions help analytical and medical equipment manufacturers accelerate the fluid handling design and engineering phase of new product development. Are you an analytical or medical OEM design engineer struggling with compressed product development timelines? Do you need a rapid solution to complex fluidic system challenges? The Rapid Engineered Solutions program from Emerson is the perfect solution…
  • Embedded Spectral Process Analytic Technology

    Effective quality assurance processes are essential in pharmaceutical and biopharmaceutical manufacturing processes. Deploying Process Analytical Technologies (PAT) is one way these manufacturers have driven business improvements. Pharma Manufacturing magazine’s Pharma Innovation Awards highlights the technologies and systems driving improvements across manufacturing operations. Their December 2022 article, Pharma Innovation…
  • Embedded Spectral Process Analytic Technology

    Effective quality assurance processes are essential in pharmaceutical and biopharmaceutical manufacturing processes. Deploying Process Analytical Technologies (PAT) is one way these manufacturers have driven business improvements. Pharma Manufacturing magazine’s Pharma Innovation Awards highlights the technologies and systems driving improvements across manufacturing operations. Their December 2022 article, Pharma Innovation…
  • Embedded Spectral Process Analytic Technology

    Effective quality assurance processes are essential in pharmaceutical and biopharmaceutical manufacturing processes. Deploying Process Analytical Technologies (PAT) is one way these manufacturers have driven business improvements. Pharma Manufacturing magazine’s Pharma Innovation Awards highlights the technologies and systems driving improvements across manufacturing operations. Their December 2022 article, Pharma Innovation…
  • Improving Digital Maturity is Key to Life Sciences Success

    In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the life sciences marketplace. In collaboration with other life sciences leaders, Emerson’s Michalle Adkins contributed to a BioPhorum paper outlining a vision…
  • Improving Digital Maturity is Key to Life Sciences Success

    In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the life sciences marketplace. In collaboration with other life sciences leaders, Emerson’s Michalle Adkins contributed to a BioPhorum paper outlining a vision…
  • Improving Digital Maturity is Key to Life Sciences Success

    In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the life sciences marketplace. In collaboration with other life sciences leaders, Emerson’s Michalle Adkins contributed to a BioPhorum paper outlining a vision…
  • Real-World Implications of Spectral PAT for Life Sciences

    There is a growing buzz around spectral process analytical technology (PAT) for the life sciences industry. Spectral PAT sounds really fancy. What is it, and how can it affect my company’s mission to produce treatments and cures that improve the quality of life for our patients? Let’s start with the basics. The ultimate value proposition of every life sciences manufacturer is to produce goods that dramatically improve…
  • Real-World Implications of Spectral PAT for Life Sciences

    There is a growing buzz around spectral process analytical technology (PAT) for the life sciences industry. Spectral PAT sounds really fancy. What is it, and how can it affect my company’s mission to produce treatments and cures that improve the quality of life for our patients? Let’s start with the basics. The ultimate value proposition of every life sciences manufacturer is to produce goods that dramatically improve…
  • Real-World Implications of Spectral PAT for Life Sciences

    There is a growing buzz around spectral process analytical technology (PAT) for the life sciences industry. Spectral PAT sounds really fancy. What is it, and how can it affect my company’s mission to produce treatments and cures that improve the quality of life for our patients? Let’s start with the basics. The ultimate value proposition of every life sciences manufacturer is to produce goods that dramatically improve…
  • Leverage Life Sciences Software to Reduce Time to Market

    The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However, while many life sciences teams have moved to electronic records software , many teams are still inadvertently creating data silos—both horizontally across business…
  • Leverage Life Sciences Software to Reduce Time to Market

    The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However, while many life sciences teams have moved to electronic records software , many teams are still inadvertently creating data silos—both horizontally across business…
  • Leverage Life Sciences Software to Reduce Time to Market

    The days of maintaining paper records across the life sciences development and production pipeline are gone. Today’s regulatory requirements, not to mention the complexity of new treatments, requires organization that can only be provided electronically. However, while many life sciences teams have moved to electronic records software , many teams are still inadvertently creating data silos—both horizontally across business…
  • Module Type Package Unlocks the Flexibility Driving Pharma Innovation

    There can be little question that Industry 4.0 technologies are reshaping the way life sciences companies operate. In the wake of the rapid development of vaccines during the COVID-19 pandemic , more facilities than ever are being “born digital.” Some of these born-digital facilities are the result of new organizations with entirely digital strategies, and others are biopharmaceutical organizations that have been around…
  • Module Type Package Unlocks the Flexibility Driving Pharma Innovation

    There can be little question that Industry 4.0 technologies are reshaping the way life sciences companies operate. In the wake of the rapid development of vaccines during the COVID-19 pandemic , more facilities than ever are being “born digital.” Some of these born-digital facilities are the result of new organizations with entirely digital strategies, and others are biopharmaceutical organizations that have been around…
  • Module Type Package Unlocks the Flexibility Driving Pharma Innovation

    There can be little question that Industry 4.0 technologies are reshaping the way life sciences companies operate. In the wake of the rapid development of vaccines during the COVID-19 pandemic , more facilities than ever are being “born digital.” Some of these born-digital facilities are the result of new organizations with entirely digital strategies, and others are biopharmaceutical organizations that have been around…
  • Let your Personnel Lead you to the Adaptive Plant

    On Monday at the Emerson Exchange Users’ Conference , Emerson’s Michalle Adkins and AbbVie’s Jeff Ziolkowski moderated a panel with Fujifilm’s Soren Skerris , Takeda’s Dr. Nina Schwalb , Eli Lilly’s James Weber , and Emerson’s Christian Berg . The experts shared the strategies they have employed and the lessons they’ve learned on their journey across the BioPhorum Digital Plant Maturity Model toward creating adaptive…
  • Let your Personnel Lead you to the Adaptive Plant

    On Monday at the Emerson Exchange Users’ Conference , Emerson’s Michalle Adkins and AbbVie’s Jeff Ziolkowski moderated a panel with Fujifilm’s Soren Skerris , Takeda’s Dr. Nina Schwalb , Eli Lilly’s James Weber , and Emerson’s Christian Berg . The experts shared the strategies they have employed and the lessons they’ve learned on their journey across the BioPhorum Digital Plant Maturity Model toward creating adaptive…
  • Let your Personnel Lead you to the Adaptive Plant

    On Monday at the Emerson Exchange Users’ Conference , Emerson’s Michalle Adkins and AbbVie’s Jeff Ziolkowski moderated a panel with Fujifilm’s Soren Skerris , Takeda’s Dr. Nina Schwalb , Eli Lilly’s James Weber , and Emerson’s Christian Berg . The experts shared the strategies they have employed and the lessons they’ve learned on their journey across the BioPhorum Digital Plant Maturity Model toward creating adaptive…
« 2 3 4 5 6 »